Asprosin, a novel glucogenic adipokine implicated in type 2 diabetes mellitus.

Diao, Hongcui; Li, Xue; Xu, Yeqiu; Xing, Xiuli; Pang, Shuguang

Diao, Hongcui; Li, Xue; Xu, Yeqiu; Xing, Xiuli; Pang, Shuguang.

Afiliación

Diao H; Department of Endocrinology, Jinan Central Hospital, Shandong University, Jinan, China.
Li X; Department of Infectious Diseases, Jinan Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
Xu Y; Department of Eye, Oral & Plastic Surgery, Jinan Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
Xing X; Department of Endocrinology, Jinan Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
Pang S; Department of Endocrinology, Jinan Central Hospital, Shandong University, Jinan, China; Department of Endocrinology, Jinan Central Hospital Affiliated to Shandong First Medical University, Jinan, China. Electronic address: shuguangpang@163.com.

J Diabetes Complications ; 37(11): 108614, 2023 11.

Article en En | MEDLINE | ID: mdl-37769508

Asunto(s)

Diabetes Mellitus Tipo 2; Resistencia a la Insulina; Hormonas Peptídicas; Humanos; Adipoquinas; Hormonas Peptídicas/genética; Glucosa/metabolismo

Palabras clave

Asprosin; Blood glucose; Diabetes mellitus; FBN1; Insulin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resistencia a la Insulina / Hormonas Peptídicas / Diabetes Mellitus Tipo 2 Límite: Humans Idioma: En Revista: J Diabetes Complications Asunto de la revista: ENDOCRINOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google